The board of directors of Evergrande Health Industry Group Limited announced that Mr. Tong Ming has resigned as an executive Director with effect from March 23, 2016 due to his other career development. The board also announced that Mr. Peng Sheng has been appointed as an executive Director and the Chief Executive Officer of the company with effect from March 23, 2016. Mr. Peng, has broad international perspective and extensive management and working experience in multinational companies.

He has managed businesses and teams in the United States of America, Europe and China. Before joining the Company, Mr. Peng, as an expert returning from abroad, was the Managing Vice President and the Chief Technology Officer of Guangdong Hengjian Nucleus Medical Industry Co. Ltd. under the Guangdong State-owned Assets Supervision and Administration Commission of the State Council to lead a series of significant commercial negotiations on technology and the development of particle radiation therapy equipment.

Before returning to China, Mr. Peng worked in Varian Medical Systems Inc. of the US, a world leader in radiation therapy equipment for several years to lead the teams in the US and Europe to develop the proton therapy device of the new generation. Before that, Mr. Peng had worked for many national laboratories in the US and the SLAC National Accelerator Laboratory for several years and was a famous expert in large-scale computer control system and information processing.